beta
MBVX
MabVax Therapeutics Holdings Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
MabVax Therapeutics Holdings Inc is a development-stage biopharmaceutical company which discovers, develops, and commercializes small molecule drugs to treat cancer-related illnesses.
Market Cap: 17.5 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.mabvax.com
Shares Outstanding: 20.6 Million
Float: 8.42 Million
Dividend: 0.0 (0.0%)
Beta: 1.529461
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1476 trading days
From: 2013-01-11 To: 2018-07-13
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-08-17 | 7.4 | 1.0 | 7.4 | |||
| 2014-09-10 | 8.0 | 1.0 | 8.0 | |||
| 2018-02-16 | 3.0 | 1.0 | 3.0 |